Evaluation of KRAS Mutations, Angiogenic Biomarkers, and DCE-MRI in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Sorafenib
Kelly, R. J., Rajan, A., Force, J., Lopez-Chavez, A., Keen, C., Cao, L., Yu, Y., Choyke, P., Turkbey, B., Raffeld, M., Xi, L., Steinberg, S. M., Wright, J. J., Kummar, S., Gutierrez, M., Giaccone, G.Volume:
17
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-10-2331
Date:
March, 2011
File:
PDF, 405 KB
english, 2011